The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Organ Transplant Immunosuppressant Drugs Market Research Report 2025

Global Organ Transplant Immunosuppressant Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426233

No of Pages : 78

Ask Your Query

Synopsis

Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.

The global Organ Transplant Immunosuppressant Drugs market was valued at US$ 5102 million in 2023 and is anticipated to reach US$ 6403.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Organ Transplant Immunosuppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Immunosuppressant Drugs.

Report Scope

The Organ Transplant Immunosuppressant Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Transplant Immunosuppressant Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Organ Transplant Immunosuppressant Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Roche
  • Sanofi
  • Astellas Pharma, Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer, Inc.
  • Veloxis Pharmaceuticals

Segment by Type

  • Antibodies
  • Antiproliferative Agents
  • Calcineurin Inhibitors
  • mTOR Inhibitors
  • Steroids

Segment by Application

  • Bone Marrow Transplant
  • Heart Transplant
  • Kidney Transplant
  • Liver Transplant
  • Lung Transplant

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Organ Transplant Immunosuppressant Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Organ Transplant Immunosuppressant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Organ Transplant Immunosuppressant Drugs Market Overview
1.1 Product Overview and Scope of Organ Transplant Immunosuppressant Drugs
1.2 Organ Transplant Immunosuppressant Drugs Segment by Type
1.2.1 Global Organ Transplant Immunosuppressant Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Antibodies
1.2.3 Antiproliferative Agents
1.2.4 Calcineurin Inhibitors
1.2.5 mTOR Inhibitors
1.2.6 Steroids
1.3 Organ Transplant Immunosuppressant Drugs Segment by Application
1.3.1 Global Organ Transplant Immunosuppressant Drugs Market Value by Application: (2024-2030)
1.3.2 Bone Marrow Transplant
1.3.3 Heart Transplant
1.3.4 Kidney Transplant
1.3.5 Liver Transplant
1.3.6 Lung Transplant
1.4 Global Organ Transplant Immunosuppressant Drugs Market Size Estimates and Forecasts
1.4.1 Global Organ Transplant Immunosuppressant Drugs Revenue 2019-2030
1.4.2 Global Organ Transplant Immunosuppressant Drugs Sales 2019-2030
1.4.3 Global Organ Transplant Immunosuppressant Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Organ Transplant Immunosuppressant Drugs Market Competition by Manufacturers
2.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Organ Transplant Immunosuppressant Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Organ Transplant Immunosuppressant Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Organ Transplant Immunosuppressant Drugs, Product Type & Application
2.7 Organ Transplant Immunosuppressant Drugs Market Competitive Situation and Trends
2.7.1 Organ Transplant Immunosuppressant Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Organ Transplant Immunosuppressant Drugs Players Market Share by Revenue
2.7.3 Global Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario by Region
3.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Organ Transplant Immunosuppressant Drugs Global Organ Transplant Immunosuppressant Drugs Sales by Region: 2019-2030
3.2.1 Global Organ Transplant Immunosuppressant Drugs Sales by Region: 2019-2024
3.2.2 Global Organ Transplant Immunosuppressant Drugs Sales by Region: 2025-2030
3.3 Global Organ Transplant Immunosuppressant Drugs Global Organ Transplant Immunosuppressant Drugs Revenue by Region: 2019-2030
3.3.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Region: 2019-2024
3.3.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Region: 2025-2030
3.4 North America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
3.4.1 North America Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)
3.4.3 North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
3.5.1 Europe Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)
3.5.3 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
3.7.1 Latin America Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)
3.7.3 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2019-2030)
4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2019-2024)
4.1.2 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2025-2030)
4.1.3 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2019-2030)
4.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2019-2030)
4.2.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2019-2024)
4.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Type (2025-2030)
4.2.3 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Organ Transplant Immunosuppressant Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2019-2030)
5.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2019-2024)
5.1.2 Global Organ Transplant Immunosuppressant Drugs Sales by Application (2025-2030)
5.1.3 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2019-2030)
5.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2019-2030)
5.2.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2019-2024)
5.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Application (2025-2030)
5.2.3 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Organ Transplant Immunosuppressant Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Organ Transplant Immunosuppressant Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Astellas Pharma, Inc.
6.3.1 Astellas Pharma, Inc. Corporation Information
6.3.2 Astellas Pharma, Inc. Description and Business Overview
6.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product Portfolio
6.3.5 Astellas Pharma, Inc. Recent Developments/Updates
6.4 GlaxoSmithKline plc
6.4.1 GlaxoSmithKline plc Corporation Information
6.4.2 GlaxoSmithKline plc Description and Business Overview
6.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product Portfolio
6.4.5 GlaxoSmithKline plc Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Pfizer, Inc.
6.6.1 Pfizer, Inc. Corporation Information
6.6.2 Pfizer, Inc. Description and Business Overview
6.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product Portfolio
6.6.5 Pfizer, Inc. Recent Developments/Updates
6.7 Veloxis Pharmaceuticals
6.6.1 Veloxis Pharmaceuticals Corporation Information
6.6.2 Veloxis Pharmaceuticals Description and Business Overview
6.6.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product Portfolio
6.7.5 Veloxis Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Organ Transplant Immunosuppressant Drugs Industry Chain Analysis
7.2 Organ Transplant Immunosuppressant Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Organ Transplant Immunosuppressant Drugs Production Mode & Process
7.4 Organ Transplant Immunosuppressant Drugs Sales and Marketing
7.4.1 Organ Transplant Immunosuppressant Drugs Sales Channels
7.4.2 Organ Transplant Immunosuppressant Drugs Distributors
7.5 Organ Transplant Immunosuppressant Drugs Customers
8 Organ Transplant Immunosuppressant Drugs Market Dynamics
8.1 Organ Transplant Immunosuppressant Drugs Industry Trends
8.2 Organ Transplant Immunosuppressant Drugs Market Drivers
8.3 Organ Transplant Immunosuppressant Drugs Market Challenges
8.4 Organ Transplant Immunosuppressant Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock